Welcome!

Machine Learning Authors: Pat Romanski, Yeshim Deniz, Liz McMillan, Elizabeth White, Zakia Bouachraoui

News Feed Item

Finesse Solutions and Thermo Fisher Scientific Renew Bilateral Supply Agreement for Control Systems and Single-Use Bioreactors

SANTA CLARA, Calif., Jan. 8, 2013 /PRNewswire/ -- Finesse Solutions, Inc., a manufacturer of measurement and control solutions for life sciences process applications, announced the renewal of their bilateral supply agreement with Thermo Fisher Scientific Inc. For the last 5 years and with over 200 collaborative projects connecting the market leading Thermo Scientific HyPerforma Single-Use Bioreactor with Finesse's TruFluor single-use sensors and TruBio automation systems, the relationship between both companies continues to remain strong and allows both companies to offer customers seamless support for single-use systems through faster installation, connectivity, service, and support.

The bilateral relationship allows Finesse to continue offering its highly configurable, turn-key G3-series cGMP systems to the market.  Based on the DeltaV® control platform from Emerson, Finesse controllers allows users to scale their processes seamlessly from 50L single use bioreactors for lab-scale and R&D applications into cGMP single-use process trains having volumes up to 2,000L.The agreement has enabled the market leading Thermo Scientific HyPerforma Single-Use Bioreactor TurnKey (S.U.B. TK) solution, which combines a next generation Thermo S.U.B. with Finesse's state-of-the-art G3mini controller having either a DeltaV of mC control platform. Now customers can choose either the Hyperforma S.U.B. TK or highly customized Finesse control systems with fully integrated S.U.B bioreactors.

"Thermo Fisher Scientific and Finesse have a long history of successful collaboration, not only through integrating S.U.B.s as one option of our open architecture approach, but also through development of the HyPerforma S.U.B. TK system," said Millie Ullah, senior product manager for single-use technology for Thermo Scientific cell culture and bioprocessing products. "The renewal of the supply agreement reinforces our partnership and provides our customers with assurance that we are jointly committed to supporting our customers through turnkey single use bioreactors with a choice of control platforms having either DeltaV or mC automation."

"Thermo Fisher Scientific's S.U.B.s have and continue to represent a significant opportunity for our G3-series controllers as well as our single-use TruFluor and TruTorr sensors," stated Barbara Paldus, CEO of Finesse.  "In single-use cGMP applications, our DeltaV-based control platform will enable efficient implementation of production capacity, whereas in research and process development for our Wintel-based TruBio mC control platform is expected to merge state-of-the-art control with a great user experience."

About Finesse Solutions, Inc.

California-based Finesse Solutions, Inc., has established a proven record in providing turnkey, scalable solutions for single-use upstream bioprocessing. The Finesse product platform includes an extensive portfolio of novel disposable sensors, modular configure-to-order automation hardware, and intelligent software that can harmonize global bioprocess information and technology transfer. Finesse also offers a complete set of services including startup, commissioning, and validation for rapid and reliable deployment of single-use equipment into cGMP manufacturing applications. Visit www.finesse.com.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of $12 billion, we have approximately 39,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through three premier brands, Thermo Scientific, Fisher Scientific and Unity™ Lab Services, which offer a unique combination of innovative technologies, convenient purchasing options and a single solution for laboratory operations management. Our products and services help our customers solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Visit www.thermofisher.com.  To learn more about Thermo Scientific Cell Culture and Bioprocessing technology, visit www.thermoscientific.com/bioprocessing.

SOURCE Finesse Solutions, Inc.

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

CloudEXPO Stories
With more than 30 Kubernetes solutions in the marketplace, it's tempting to think Kubernetes and the vendor ecosystem has solved the problem of operationalizing containers at scale or of automatically managing the elasticity of the underlying infrastructure that these solutions need to be truly scalable. Far from it. There are at least six major pain points that companies experience when they try to deploy and run Kubernetes in their complex environments. In this presentation, the speaker will detail these pain points and explain how cloud can address them.
The deluge of IoT sensor data collected from connected devices and the powerful AI required to make that data actionable are giving rise to a hybrid ecosystem in which cloud, on-prem and edge processes become interweaved. Attendees will learn how emerging composable infrastructure solutions deliver the adaptive architecture needed to manage this new data reality. Machine learning algorithms can better anticipate data storms and automate resources to support surges, including fully scalable GPU-centric compute for the most data-intensive applications. Hyperconverged systems already in place can be revitalized with vendor-agnostic, PCIe-deployed, disaggregated approach to composable, maximizing the value of previous investments.
When building large, cloud-based applications that operate at a high scale, it's important to maintain a high availability and resilience to failures. In order to do that, you must be tolerant of failures, even in light of failures in other areas of your application. "Fly two mistakes high" is an old adage in the radio control airplane hobby. It means, fly high enough so that if you make a mistake, you can continue flying with room to still make mistakes. In his session at 18th Cloud Expo, Lee Atchison, Principal Cloud Architect and Advocate at New Relic, discussed how this same philosophy can be applied to highly scaled applications, and can dramatically increase your resilience to failure.
Machine learning has taken residence at our cities' cores and now we can finally have "smart cities." Cities are a collection of buildings made to provide the structure and safety necessary for people to function, create and survive. Buildings are a pool of ever-changing performance data from large automated systems such as heating and cooling to the people that live and work within them. Through machine learning, buildings can optimize performance, reduce costs, and improve occupant comfort by sharing information within the building and with outside city infrastructure via real time shared cloud capabilities.
As Cybric's Chief Technology Officer, Mike D. Kail is responsible for the strategic vision and technical direction of the platform. Prior to founding Cybric, Mike was Yahoo's CIO and SVP of Infrastructure, where he led the IT and Data Center functions for the company. He has more than 24 years of IT Operations experience with a focus on highly-scalable architectures.